Rocket Doctor AI, a publicly listed company focused on creating AI tools to enhance healthcare accessibility, has entered into a digital marketing collaboration with B2i Digital. This partnership, set to begin on or around August 5, 2026, will run across 12 platforms. These platforms include major social networks like LinkedIn, Facebook, and Instagram, as well as digital newsletters, webinars, and paid ad campaigns. This strategy aims to increase the company's visibility and engagement with potential investors and the broader healthcare community.
What the deal includes
As part of the digital marketing arrangement, B2i Digital will build and manage a company profile on its website, run paid digital advertising campaigns, and create content for Rocket Doctor AI. The partnership also encompasses email marketing to the investment community and introducing the company to relevant investor conferences and speaking events. The agreement is set for an initial three-month term, with Rocket Doctor AI having the option to extend it for six or 12 months by paying additional fees. In the absence of 30 days' written notice from either party, the contract will not automatically continue beyond its initial or extended term.
The initial cash payment for the three-month service is $21,375 USD. If Rocket Doctor AI chooses to extend the agreement for another six months, an additional $14,625 will be required. For a 12-month extension, the extra cost rises to $32,625. Importantly, the compensation does not include any stock options for B2i Digital, ensuring that the engagement is purely transactional and not linked to equity.
Statements from both sides
Dr. Essam Hamza, CEO of Rocket Doctor AI, expressed that the collaboration marks a key step in the company's plan to expand its influence into the U.S. market, particularly New York. He emphasized that the AI-powered medical tools developed by Rocket Doctor AI must reach patients who need them most. On the other hand, David Shapiro, CEO of B2i Digital, said his firm evaluates many potential clients but only selects a few to become featured companies. He was particularly impressed by Rocket Doctor AI's mission and the company's unique approach to solving a pressing problem in the healthcare system.
Shapiro, who is also a parent living in New York with a large family, noted that the healthcare challenges addressed by Rocket Doctor AI are something he encounters personally. He stated, “I want to be their messenger to the markets,” though he was careful to clarify that this does not equate to financial advice. This clarification is essential for transparency and to align with financial regulations and compliance requirements.
About B2i Digital
B2i Digital, established in 2021, offers a range of digital marketing and investor relations programs. The firm claims it can connect public companies with a vast network of over 1.7 million retail and institutional market participants. These connections are achieved through owned media platforms, video content, email campaigns, and national newswire syndication. The firm operates several programs, such as Featured Conference, Featured Company, and Featured Expert, which together aim to maximize exposure for companies and professionals in the market.
Shapiro, a former executive at Maxim Group, highlighted that B2i Digital has organized over 120 investor conferences since its inception. The firm's strategic approach is described as “From Marketing to Meetings,” combining digital outreach with in-person engagement to effectively connect with investors and industry professionals. This dual approach ensures a broader reach and fosters meaningful connections in the capital markets.
The announcement includes B2i Digital’s contact information and website. The firm is defined as an independent, or “arm’s-length,” service provider for this project, reinforcing that it acts in a neutral and professional manner. This distinction is crucial to maintain credibility and objectivity in their advisory role.
What Rocket Doctor AI offers
Rocket Doctor AI provides physician-built, AI-powered digital health solutions. The company’s standout offering is the Global Library of Medicine (GLM), a decision support system developed with input from hundreds of physicians worldwide. This tool aims to assist healthcare professionals in making informed decisions and delivering high-quality care to patients. The company's platform is designed to revolutionize the healthcare sector by making services more efficient and accessible through advanced technology.
Rocket Doctor AI reports that it has supported over 350 MDs in managing care for more than 750,000 patient visits. The platform helps doctors streamline their workflows, reduce administrative burdens, and maintain high standards of care. The company's goals include supporting physician autonomy while simultaneously improving patients' access to reliable and top-tier medical services. By leveraging AI, Rocket Doctor AI aims to bridge the gaps in healthcare delivery and promote better outcomes for patients and providers alike.